Skip Nav Destination
CONTINUING MEDICAL EDUCATION (CME) QUESTIONS|
November 19, 2020
Connected Content
A related article has been published:
CANOMAD: a neurological monoclonal gammopathy of clinical significance that benefits from B-cell–targeted therapies
A commentary has been published:
Monoclonal IgM and neuropathy: not always anti-MAG
Citation
CANOMAD syndrome. Blood 2020; 136 (21): 2481. doi: https://doi.org/10.1182/blood.2020009573
Download citation file:
November 19 2020
Advertisement intended for health care professionals
Cited By
Advertisement intended for health care professionals
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal